Works matching DE "NEUTRALIZATION tests"


Results: 747
    1
    2
    3
    4
    5
    6

    СИЫР ШЕШЕГІНЕ ҚАРСЫ ЕГІЛГЕН ЖАНУАРЛАРДЫҢ ҚАН САРЫСУЫНАН ВИРУСТЫ БЕЙТАРАПТАУШЫ АНТИДЕНЕЛЕРДІ БЕЙТАРАПТАУ РЕАКЦИЯСЫНДА АНЫҚТАУ ҮШІН ВИРУСТЫҢ ТИІМДІ ДОЗАСЫН ТАҢДАУ.

    Published in:
    Eurasian Journal of Applied Biotechnology, 2024, n. 3, p. 84, doi. 10.11134/btp.3.2024.9
    By:
    • Қ., Жүгінісов;
    • Б., Мырзахметова;
    • М., Туысқанова;
    • А., Алиева
    Publication type:
    Article
    7
    8
    9

    B亚型禽偏肺病毒灭活疫苗对商品肉鸡免疫效果的研究.

    Published in:
    Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2022, v. 44, n. 10, p. 1071, doi. 10.3969/j.issn.1008-0589.202201033
    By:
    • 包媛玲;
    • 何锡栋;
    • 于蒙蒙;
    • 刘 鹏;
    • 陶蓉蓉;
    • 肖美丽;
    • 王素艳;
    • 李欣翼;
    • 胡守平;
    • 刘爱晶;
    • 张艳萍;
    • 刘长军;
    • 祁小乐;
    • 王笑梅;
    • 高玉龙
    Publication type:
    Article
    10

    鹅星状病毒衣壳蛋白间接 ELISA 检测方法的建立.

    Published in:
    Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2022, v. 44, n. 8, p. 850, doi. 10.3969/j.issn.1008-0589.202112001
    By:
    • 张帆帆;
    • 李海琴;
    • 谭美芳;
    • 杨 群;
    • 涂凌云;
    • 康冬柳;
    • 罗士仙;
    • 黄奕雯;
    • 曾艳兵;
    • 谭 佳;
    • 黄江南;
    • 谢金防;
    • 韦启鹏;
    • 康昭风
    Publication type:
    Article
    11
    12
    13
    14
    15

    Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates.

    Published in:
    Vaccines, 2024, v. 12, n. 10, p. 1099, doi. 10.3390/vaccines12101099
    By:
    • Stepanova, Ekaterina;
    • Isakova-Sivak, Irina;
    • Matyushenko, Victoria;
    • Mezhenskaya, Daria;
    • Kudryavtsev, Igor;
    • Kostromitina, Arina;
    • Chistiakova, Anna;
    • Rak, Alexandra;
    • Bazhenova, Ekaterina;
    • Prokopenko, Polina;
    • Kotomina, Tatiana;
    • Donina, Svetlana;
    • Novitskaya, Vlada;
    • Sivak, Konstantin;
    • Karal-Ogly, Dzhina;
    • Rudenko, Larisa
    Publication type:
    Article
    16

    Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial.

    Published in:
    Vaccines, 2024, v. 12, n. 9, p. 1001, doi. 10.3390/vaccines12091001
    By:
    • Lemos-Pérez, Gilda;
    • Barrese-Pérez, Yinet;
    • Chacón-Quintero, Yahima;
    • Uranga-Piña, Rolando;
    • Avila-Albuerne, Yisel;
    • Figueroa-García, Iglermis;
    • Calderín-Marín, Osaida;
    • Gómez-Vázquez, Martha M.;
    • Piñera-Martínez, Marjoris;
    • Chávez-Valdés, Sheila;
    • Martínez-Rosales, Ricardo;
    • Ávila-Díaz, Lismary;
    • Vázquez-Arteaga, Amalia;
    • González-Formental, Hany;
    • Freyre-Corrales, Giselle;
    • Coizeau-Rodríguez, Edelgis;
    • Limonta-Fernández, Miladys;
    • Ayala-Avila, Marta;
    • Martínez-Díaz, Eduardo;
    • Pimentel-Vazquez, Eulogio
    Publication type:
    Article
    17
    18
    19

    Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac ® and ChAdOx1-S Vaccines for SARS-CoV-2.

    Published in:
    Vaccines, 2024, v. 12, n. 4, p. 344, doi. 10.3390/vaccines12040344
    By:
    • Putri, Nina Dwi;
    • Zhafira, Aqila Sakina;
    • Wicaksana, Pratama;
    • Sinto, Robert;
    • Hanafi, Gryselda;
    • Wiyono, Lowilius;
    • Prayitno, Ari;
    • Karyanti, Mulya Rahma;
    • Naibaho, Murni Luciana;
    • Febrina, Febrina;
    • Sukandar, Hadyana;
    • Setiawaty, Vivi;
    • Mursinah, Mursinah;
    • Putra, Ahmat Rediansya;
    • Wibowo, Heri;
    • Sundoro, Julitasari;
    • Satari, Hindra Irawan;
    • Oktavia, Dwi;
    • Multihartina, Pretty;
    • Harbuwono, Dante Saksono
    Publication type:
    Article
    20
    21
    22
    23
    24

    Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection.

    Published in:
    Vaccines, 2023, v. 11, n. 11, p. 1644, doi. 10.3390/vaccines11111644
    By:
    • Sobhani, Kimia;
    • Cheng, Susan;
    • Binder, Raquel A.;
    • Mantis, Nicholas J.;
    • Crawford, James M.;
    • Okoye, Nkemakonam;
    • Braun, Jonathan G.;
    • Joung, Sandy;
    • Wang, Minhao;
    • Lozanski, Gerard;
    • King, Christopher L.;
    • Roback, John D.;
    • Granger, Douglas A.;
    • Boppana, Suresh B.;
    • Karger, Amy B.
    Publication type:
    Article
    25
    26
    27

    Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial.

    Published in:
    Vaccines, 2023, v. 11, n. 8, p. 1329, doi. 10.3390/vaccines11081329
    By:
    • Samoud, Samar;
    • Bettaieb, Jihene;
    • Gdoura, Mariem;
    • Kharroubi, Ghassen;
    • Ben Ghachem, Feriel;
    • Zamali, Imen;
    • Ben Hmid, Ahlem;
    • Salem, Sadok;
    • Gereisha, Ahmed Adel;
    • Dellagi, Mongi;
    • Hogga, Nahed;
    • Gharbi, Adel;
    • Baccouche, Amor;
    • Gharbi, Manel;
    • Khemissi, Chadha;
    • Akili, Ghada;
    • Slama, Wissem;
    • Chaieb, Nabila;
    • Galai, Yousr;
    • Louzir, Hechmi
    Publication type:
    Article
    28

    A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures.

    Published in:
    Vaccines, 2023, v. 11, n. 8, p. 1311, doi. 10.3390/vaccines11081311
    By:
    • Wu, Xiaohong;
    • Li, Jia;
    • Zhou, Lei;
    • Chen, Jianmin;
    • Jin, Zhongqiang;
    • Meng, Qingwei;
    • Chai, Jing;
    • Gao, Hongxia;
    • Wang, Yunpeng;
    • Zhao, Danhua;
    • Wu, Heng;
    • Yu, Jieran;
    • Chen, Nan;
    • Wang, Yanan;
    • Lin, Yuan;
    • Huang, Peifang;
    • Li, Yuhua;
    • Zhang, Yuhui
    Publication type:
    Article
    29

    Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.

    Published in:
    Vaccines, 2023, v. 11, n. 7, p. 1234, doi. 10.3390/vaccines11071234
    By:
    • Ates, Ihsan;
    • Batirel, Ayse;
    • Aydin, Mehtap;
    • Karadag, Fatma Yilmaz;
    • Erden, Abdulsamet;
    • Kucuksahin, Orhan;
    • Armagan, Berkan;
    • Guven, Serdar Can;
    • Karakas, Ozlem;
    • Gokdemir, Selim;
    • Altunal, Lutfiye Nilsun;
    • Buber, Aslihan Ayse;
    • Gemcioglu, Emin;
    • Zengin, Oguzhan;
    • Inan, Osman;
    • Sahiner, Enes Seyda;
    • Korukluoglu, Gulay;
    • Sezer, Zafer;
    • Ozdarendeli, Aykut;
    • Omma, Ahmet
    Publication type:
    Article
    30

    Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis.

    Published in:
    Vaccines, 2023, v. 11, n. 7, p. 1161, doi. 10.3390/vaccines11071161
    By:
    • Hsiao, Shih-Hsin;
    • Sue, Yuh-Mou;
    • Kao, Chih-Chin;
    • Chang, Hui-Wen;
    • Lin, Yen-Chung;
    • Hung, Ching-Sheng;
    • Hsieh, Yi-Chen;
    • Hong, Shiao-Ya;
    • Chung, Chi-Li;
    • Chang, Jer-Hwa;
    • Su, Ying-Shih;
    • Liu, Ming-Che;
    • Lai, Kevin Shu-Leung;
    • Chien, Ko-Ling;
    • Wang, Jude Chu-Chun;
    • Cheng, Chung-Yi;
    • Fang, Te-Chao
    Publication type:
    Article
    31

    Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6–7 Months: A Phase 4, Randomized, Controlled Trial.

    Published in:
    Vaccines, 2023, v. 11, n. 4, p. 862, doi. 10.3390/vaccines11040862
    By:
    • Xiao, Yanhui;
    • Guo, Xue;
    • Zhang, Min;
    • Chen, Yaping;
    • Zhang, Yanyang;
    • Yu, Xiaoqing;
    • Luo, Linyun;
    • Chen, Haiping;
    • Xu, Weichai;
    • Liu, Haibo;
    • Wu, Lixia;
    • Hou, Renwu;
    • Ma, Yong;
    • Long, Lin;
    • Ruan, Jiewei;
    • Chen, Wei;
    • Yang, Xiaoming
    Publication type:
    Article
    32

    A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults.

    Published in:
    Vaccines, 2023, v. 11, n. 4, p. 723, doi. 10.3390/vaccines11040723
    By:
    • Zhang, Ruiqi;
    • Chan, Kwok-Hung;
    • Wang, Pui;
    • Zhou, Runhong;
    • Yau, Henry Kwong-Chi;
    • Wong, Creany Ka-Wai;
    • Au, Meena Wai-Lam;
    • Tam, Anthony Raymond;
    • Ng, Chi-Tao;
    • Lou, Matthew Kwok-Chung;
    • Liu, Na;
    • Huang, Haode;
    • Deng, Shaofeng;
    • Tam, Rachel Chun-Yee;
    • Liu, Ying;
    • Long, Teng;
    • Tsoi, Hoi-Wah;
    • Ng, Miko K. W.;
    • Cai, Jian-Piao;
    • To, Kelvin Kai-Wang
    Publication type:
    Article
    33

    Longitudinal Profiles of Anti-Platelet Factor 4 Antibodies in Thai People Who Received ChAdOx1 nCoV-19 Vaccination.

    Published in:
    Vaccines, 2023, v. 11, n. 3, p. 692, doi. 10.3390/vaccines11030692
    By:
    • Hantrakun, Nonthakorn;
    • Sinsakolwat, Peampost;
    • Tantiworawit, Adisak;
    • Rattarittamrong, Ekarat;
    • Rattanathammethee, Thanawat;
    • Hantrakool, Sasinee;
    • Piriyakhuntorn, Pokpong;
    • Punnachet, Teerachat;
    • Niprapan, Piangrawee;
    • Wongtagan, Ornkamon;
    • Chaiwarith, Romanee;
    • Norasetthada, Lalita;
    • Chai-Adisaksopha, Chatree
    Publication type:
    Article
    34
    35

    Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial.

    Published in:
    Vaccines, 2023, v. 11, n. 2, p. 455, doi. 10.3390/vaccines11020455
    By:
    • Dodaran, Masoud Solaymani;
    • Banihashemi, Seyed Reza;
    • Es-haghi, Ali;
    • Mehrabadi, Mohammad Hossein Fallah;
    • Nofeli, Mojtaba;
    • Mokarram, Ali Rezaei;
    • Mokhberalsafa, Ladan;
    • Sadeghi, Fariba;
    • Ranjbar, Alireza;
    • Ansarifar, Akram;
    • Mohazzab, Arash;
    • Setarehdan, Seyed Amin;
    • Bagheri Amiri, Fahimeh;
    • Mohseni, Vahideh;
    • Hajimoradi, Monireh;
    • Ghahremanzadeh, Neda;
    • Razzaz, Seyed Hossein;
    • Masoomi, Safdar;
    • Taghdiri, Maryam;
    • Bagheri, Mohsen
    Publication type:
    Article
    36
    37

    One-Year Post-Vaccination Longitudinal Follow-Up of Quantitative SARS-CoV-2 Anti-Spike Total Antibodies in Health Care Professionals and Evaluation of Correlation with Surrogate Neutralization Test.

    Published in:
    Vaccines, 2023, v. 11, n. 2, p. 355, doi. 10.3390/vaccines11020355
    By:
    • Tuyji Tok, Yesim;
    • Can Sarinoglu, Rabia;
    • Ordekci, Seyhan;
    • Yilmaz, Serife;
    • Ozcolpan, Gunes;
    • Bayram, Aysen;
    • Nohut, Okan Kadir;
    • Kocer, Ipek;
    • Hasdemir, Ufuk;
    • Kuskucu, Mert Ahmet;
    • Konukoglu, Dildar;
    • Gozalan, Aysegul;
    • Midilli, Kenan;
    • Celik, Gulden
    Publication type:
    Article
    38
    39

    Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.

    Published in:
    Vaccines, 2023, v. 11, n. 2, p. 326, doi. 10.3390/vaccines11020326
    By:
    • Kudriavtsev, Aleksandr V.;
    • Vakhrusheva, Anna V.;
    • Kryuchkov, Nickolay A.;
    • Frolova, Maria E.;
    • Blagodatskikh, Konstantin A.;
    • Ivanishin, Taras V.;
    • Djonovic, Milana;
    • Romanovskaya-Romanko, Ekaterina A.;
    • Kovalenko, Anton N.;
    • Lioznov, Dmitry A.;
    • Zubkova, Tatiana G.;
    • Teplykh, Svetlana V.;
    • Oseshnyuk, Rodion A.;
    • Stukova, Marina A.;
    • Isaev, Artur A.;
    • Krasilnikov, Igor V.
    Publication type:
    Article
    40

    Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi.

    Published in:
    Vaccines, 2023, v. 11, n. 2, p. 299, doi. 10.3390/vaccines11020299
    By:
    • Al Kaabi, Nawal;
    • Yang, Yunkai;
    • Eldin Hussein, Salah;
    • Yang, Tian;
    • Abdalla, Jehad;
    • Wang, Hui;
    • Lou, Zhiyong;
    • Bakkour, Agyad;
    • Arafat, Afnan;
    • Jiang, Zhiwei;
    • Tian, Ye;
    • Xiao, Peng;
    • Zaher, Walid;
    • Eltantawy, Islam;
    • Wang, Chenlong;
    • Xu, Guangxue;
    • Zhang, Yuntao;
    • Yang, Xiaoming
    Publication type:
    Article
    41
    42
    43
    44

    Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial.

    Published in:
    Vaccines, 2022, v. 10, n. 11, p. 1800, doi. 10.3390/vaccines10111800
    By:
    • Ahi, Mohammadreza;
    • Hamidi Farahani, Ramin;
    • Basiri, Pouria;
    • Karimi Rahjerdi, Ahmad;
    • Sheidaei, Ali;
    • Gohari, Kimiya;
    • Rahimi, Zahra;
    • Gholami, Fateme;
    • Moradi, Milad;
    • Ghafoori Naeeni, Farzad;
    • Saffar, Kosar Naderi;
    • Ghasemi, Soheil;
    • Barati, Babak;
    • Moradi, Sohrab;
    • Monazah, Arina;
    • Pouranvari, Fatemeh;
    • Forooghizadeh, Mohsen
    Publication type:
    Article
    45

    Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China

    Published in:
    Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060895
    By:
    • Liu, Xiaodong;
    • Chang, Shaoying;
    • Wang, Ruize;
    • Xiao, Yanhui;
    • Li, Fangjun;
    • Xu, Qing;
    • Zhang, Shaobai;
    • Chen, Xiao;
    • Zhang, Shangxiao;
    • Zhang, Min;
    • Chen, Xiaoqi;
    • Cao, Qingfan;
    • Liu, Xiaoyu;
    • Wang, Hui;
    • Zhan, Daihong;
    • Chen, Haiping;
    • Chen, Wei;
    • Jiang, Jianyong;
    • Zhang, Chao;
    • Wang, Haijiao
    Publication type:
    Article
    46
    47

    Metrics from Wearable Devices as Candidate Predictors of Antibody Response Following Vaccination against COVID-19: Data from the Second TemPredict Study.

    Published in:
    Vaccines, 2022, v. 10, n. 2, p. 264, doi. 10.3390/vaccines10020264
    By:
    • Mason, Ashley E.;
    • Kasl, Patrick;
    • Hartogensis, Wendy;
    • Natale, Joseph L.;
    • Dilchert, Stephan;
    • Dasgupta, Subhasis;
    • Purawat, Shweta;
    • Chowdhary, Anoushka;
    • Anglo, Claudine;
    • Veasna, Danou;
    • Pandya, Leena S.;
    • Fox, Lindsey M.;
    • Puldon, Karena Y.;
    • Prather, Jenifer G.;
    • Gupta, Amarnath;
    • Altintas, Ilkay;
    • Smarr, Benjamin L.;
    • Hecht, Frederick M.
    Publication type:
    Article
    48
    49
    50